On a per-share basis, the
The biopharmaceutical company posted revenue of
Kindred Bio shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from
Copyright by Automated Insights, Inc. All rights reserved., source